Stifel Nicolaus Boosts American Well (NYSE:AMWL) Price Target to $10.00

American Well (NYSE:AMWL) had its price objective raised by equities research analysts at Stifel Nicolaus from $9.00 to $10.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “hold” rating on the stock. Stifel Nicolaus’ price target would suggest a potential downside of 17.80% from the company’s current price.

Several other equities analysts have also recently commented on the stock. Needham & Company LLC restated a “hold” rating on shares of American Well in a report on Thursday. Morgan Stanley lowered their price target on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Finally, Wells Fargo & Company raised shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price objective for the company in a research note on Monday, January 13th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $11.90.

American Well Stock Up 3.7 %

American Well stock opened at $12.17 on Thursday. The company’s fifty day simple moving average is $9.26 and its 200-day simple moving average is $9.14. American Well has a 12 month low of $5.00 and a 12 month high of $29.00. The stock has a market cap of $186.37 million, a P/E ratio of -0.83 and a beta of 1.18.

American Well (NYSE:AMWL) last posted its quarterly earnings results on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, beating the consensus estimate of ($3.04) by $0.27. American Well had a negative net margin of 84.27% and a negative return on equity of 52.49%. On average, equities research analysts expect that American Well will post -13.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On American Well

Several institutional investors and hedge funds have recently modified their holdings of the business. Senvest Management LLC lifted its stake in shares of American Well by 3.9% in the 4th quarter. Senvest Management LLC now owns 1,300,611 shares of the company’s stock valued at $9,429,000 after purchasing an additional 48,800 shares during the last quarter. Cubist Systematic Strategies LLC lifted its position in American Well by 7,673.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock worth $60,000 after acquiring an additional 181,715 shares during the last quarter. Geode Capital Management LLC lifted its position in American Well by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 147,925 shares of the company’s stock worth $1,073,000 after acquiring an additional 922 shares during the last quarter. Takeda Pharmaceutical Co. Ltd. acquired a new position in American Well during the 4th quarter worth $564,000. Finally, HighTower Advisors LLC acquired a new position in American Well during the 3rd quarter worth $355,000. Institutional investors and hedge funds own 56.05% of the company’s stock.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.